Pluri Inc. (PLUR)

SpringWorks Therapeutics Income Statement

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Revenue	1.03	0.33	0.29	0.23	-	0.02
Revenue Growth (YoY)	203.23%	13.59%	22.65%	-	-	-57.41%
Cost of Revenue	0.5	0	0.01	-	-	-
Gross Profit	0.54	0.32	0.28	0.23	-	0.02
Selling, General & Admin	9.88	10.03	11.78	17.45	21.54	8.84
Research & Development	12.25	12.45	15.75	24.38	29.08	20.66
Operating Expenses	22.13	22.48	27.52	41.83	50.62	29.5
Operating Income	-21.59	-22.16	-27.25	-41.59	-50.62	-29.48
Interest Expense	-0.86	-0.87	-0.84	-0.89	-0.08	-
Interest & Investment Income	1.05	1.31	1.08	0.58	0.49	0.38
Currency Exchange Gain (Loss)	-0.12	0.13	-1.71	0.55	0.37	-0.03
Other Non Operating Income (Expenses)	0.17	0.24	-0.17	-0.03	-0.02	-0.03
EBT Excluding Unusual Items	-21.34	-21.34	-28.89	-41.37	-49.87	-29.15
Pretax Income	-21.34	-21.34	-28.89	-41.37	-49.87	-29.15
Earnings From Continuing Operations	-21.34	-21.34	-28.89	-41.37	-49.87	-29.15
Minority Interest in Earnings	0.63	0.46	0.57	0.13	-	-
Net Income	-20.71	-20.89	-28.32	-41.24	-49.87	-29.15
Net Income to Common	-20.71	-20.89	-28.32	-41.24	-49.87	-29.15
Shares Outstanding (Basic)	6	5	5	4	4	2
Shares Outstanding (Diluted)	6	5	5	4	4	2
Shares Change (YoY)	10.88%	14.38%	13.85%	14.51%	54.49%	47.55%
EPS (Basic)	-3.61	-3.99	-6.18	-10.25	-14.19	-12.82
EPS (Diluted)	-3.61	-3.99	-6.18	-10.25	-14.19	-12.82
Free Cash Flow	-18.22	-18.34	-23.12	-36.78	-31.28	-26.64
Free Cash Flow Per Share	-3.17	-3.50	-5.05	-9.14	-8.90	-11.71
Gross Margin	52.13%	98.77%	96.86%	100.00%	-	100.00%
Operating Margin	-2087.91%	-6796.93%	-9493.38%	-17774.79%	-	-128156.52%
Profit Margin	-2003.29%	-6407.36%	-9867.94%	-17624.79%	-	-126747.83%
Free Cash Flow Margin	-1761.61%	-5626.99%	-8055.40%	-15718.38%	-	-115821.74%
EBITDA	-21.32	-21.91	-26.88	-40.54	-49.25	-27.91
D&A For EBITDA	0.27	0.25	0.36	1.05	1.37	1.57
EBIT	-21.59	-22.16	-27.25	-41.59	-50.62	-29.48

Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q